Camilla B. Holst
Copenhagen, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
The HOPX and BLBP landscape and gliogenic regions in developing human brain.
Journal: Journal of anatomy
Published: August 29, 2022
Plasma IL-8 and ICOSLG as prognostic biomarkers in glioblastoma.
Journal: Neuro-oncology advances
Published: July 21, 2021
Perspective: targeting VEGF-A and YKL-40 in glioblastoma - matter matters.
Journal: Cell cycle (Georgetown, Tex.)
Published: March 29, 2021
Systemic Immune Modulation in Gliomas: Prognostic Value of Plasma IL-6, YKL-40, and Genetic Variation in YKL-40.
Journal: Frontiers in oncology
Published: December 20, 2019
Outcome of Bevacizumab Therapy in Patients with Recurrent Glioblastoma Treated with Angiotensin System Inhibitors.
Journal: Cancer investigation
Published: February 08, 2019
Author Correction: BRCA1-regulated RRM2 expression protects glioblastoma cells from endogenous replication stress and promotes tumorigenicity.
Journal: Nature communications
Published: December 21, 2018
Plasma YKL-40 as a biomarker for bevacizumab efficacy in patients with newly diagnosed glioblastoma in the phase 3 randomized AVAglio trial.
Journal: Oncotarget
Published: May 07, 2017
BRCA1-regulated RRM2 expression protects glioblastoma cells from endogenous replication stress and promotes tumorigenicity.
Journal: Nature communications
Published: March 21, 2016
Outer brain barriers in rat and human development.
Journal: Frontiers in neuroscience
Published: November 24, 2014
Showing 1-11 of 11
Last Updated: 09/26/2026